NEW YORK, April 25, 2019 (GLOBE NEWSWIRE) — Ryah Medtech Inc. (“RYAH” or the “Company”) announced today that it has filed a Medical Device Establishment License application with Health Canada for its commercial grade cannabinoid cartridges. These cartridges are used with RYAH’s ground-breaking dose-measuring medicinal vaporizer for CBD and other cannabinoids or dry herbs.
RYAH is a data aggregation and technology company focused on the global medical cannabis market. Its robust artificial intelligence platform aggregates and correlates HIPAA-compliant medical data which is intended to help doctors and patients personalize cannabis to better predict treatment outcomes. With a strong IP portfolio, RYAH is able to gather insightful data on cannabis from seed to consumption.
“This is an exciting milestone in our company’s history,” said Gregory Wagner, President and CEO of RYAH. “The Health Canada initiative